[go: up one dir, main page]

HK1223110A1 - 流行性感冒病毒疫苗及其用途 - Google Patents

流行性感冒病毒疫苗及其用途

Info

Publication number
HK1223110A1
HK1223110A1 HK16111314.8A HK16111314A HK1223110A1 HK 1223110 A1 HK1223110 A1 HK 1223110A1 HK 16111314 A HK16111314 A HK 16111314A HK 1223110 A1 HK1223110 A1 HK 1223110A1
Authority
HK
Hong Kong
Prior art keywords
influenza virus
virus vaccines
vaccines
influenza
virus
Prior art date
Application number
HK16111314.8A
Other languages
English (en)
Inventor
Jan Wilem Meijberg
Antonietta Impagliazzo
Katarina Radosevic
Jehangir Wadia
Robert Anthony Williamson
Michelle Wagner
Zhaoqing Ding
Original Assignee
Janssen Vaccines & Prevention Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Vaccines & Prevention Bv filed Critical Janssen Vaccines & Prevention Bv
Publication of HK1223110A1 publication Critical patent/HK1223110A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
    • C07K2319/91—Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16171—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK16111314.8A 2013-05-30 2016-09-27 流行性感冒病毒疫苗及其用途 HK1223110A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13169830 2013-05-30
PCT/EP2014/060997 WO2014191435A1 (en) 2013-05-30 2014-05-27 Influenza virus vaccines and uses thereof

Publications (1)

Publication Number Publication Date
HK1223110A1 true HK1223110A1 (zh) 2017-07-21

Family

ID=48485075

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16111314.8A HK1223110A1 (zh) 2013-05-30 2016-09-27 流行性感冒病毒疫苗及其用途

Country Status (17)

Country Link
US (1) US10517941B2 (zh)
EP (1) EP3004142B1 (zh)
JP (1) JP6643981B2 (zh)
KR (1) KR102252163B1 (zh)
CN (1) CN105452270B (zh)
AU (1) AU2014273173B2 (zh)
BR (1) BR112015029635B1 (zh)
CA (1) CA2913859C (zh)
EA (1) EA034639B1 (zh)
HK (1) HK1223110A1 (zh)
IL (1) IL242824B (zh)
MX (1) MX369317B (zh)
MY (1) MY190097A (zh)
PH (1) PH12015502612B1 (zh)
SG (1) SG11201509663PA (zh)
WO (1) WO2014191435A1 (zh)
ZA (1) ZA201509229B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012343981B2 (en) 2011-11-28 2017-09-07 Janssen Vaccines & Prevention B.V. Influenza virus vaccines and uses thereof
KR102252163B1 (ko) 2013-05-30 2021-05-14 얀센 백신스 앤드 프리벤션 비.브이. 인플루엔자 바이러스 백신 및 그의 용도
WO2015187158A1 (en) * 2014-06-04 2015-12-10 Indevr, Inc. Universal capture array for multiplexed subtype-specific quantification and stability determination of influenza proteins
KR20170023124A (ko) 2014-06-26 2017-03-02 얀센 백신스 앤드 프리벤션 비.브이. 미세소관-연관 단백질 타우에 특이적으로 결합하는 항체 및 항원-결합 단편
ZA201608812B (en) 2014-06-26 2019-08-28 Janssen Vaccines & Prevention Bv Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
MX2017000395A (es) * 2014-07-10 2018-02-08 Janssen Vaccines & Prevention Bv Vacunas contra virus influenza y usos de las mismas.
JP6735269B2 (ja) 2014-07-10 2020-08-05 ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． インフルエンザウイルスワクチンおよびその使用
AU2017321883B2 (en) * 2016-09-02 2022-07-07 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
EP3624845A1 (en) 2017-05-15 2020-03-25 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
EP3624851A1 (en) 2017-05-15 2020-03-25 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
US11945841B2 (en) 2017-10-04 2024-04-02 Gerogia State University Research Foundation, Inc. Headless hemagglutin influenza vaccine
MX2020007777A (es) 2018-01-23 2020-09-18 Janssen Vaccines & Prevention Bv Vacunas contra virus de la gripe y usos de las mismas.
CA3103849A1 (en) 2018-06-27 2020-01-02 Medicago Inc. Influenza virus hemagglutinin mutants
CN114430742A (zh) 2019-09-05 2022-05-03 扬森疫苗与预防公司 流感病毒疫苗及其用途
EP4475869A2 (en) * 2022-02-11 2024-12-18 The Texas A&M University System Sars-cov-2 neutralizing synthetic proteins
WO2023198815A1 (en) 2022-04-14 2023-10-19 Janssen Vaccines & Prevention B.V. Sequential administration of adenoviruses

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
NZ230747A (en) 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
WO1990014837A1 (en) 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
SE0202110D0 (sv) 2002-07-05 2002-07-05 Isconova Ab Iscom preparation and use thereof
SE0301998D0 (sv) 2003-07-07 2003-07-07 Isconova Ab Quil A fraction with low toxicity and use thereof
KR101485197B1 (ko) 2006-09-07 2015-01-23 크루셀 홀란드 비.브이. 인플루엔자 바이러스 ｈ5ｎ1을 중화시킬 수 있는 인간 결합분자 및 그것의 용도
JP2012521786A (ja) * 2009-03-30 2012-09-20 モウント シナイ スクール オフ メディシネ インフルエンザウイルスワクチン及びその使用
CA2761648C (en) 2009-05-11 2019-03-12 Crucell Holland B.V. Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
JP2013526849A (ja) * 2010-03-30 2013-06-27 モウント シナイ スクール オフ メディシネ インフルエンザウイルスワクチン及びその使用
KR101941724B1 (ko) 2011-07-14 2019-01-23 얀센 백신스 앤드 프리벤션 비.브이. 계통발생군 1과 계통발생군 2의 인플루엔자 a형 바이러스 및 인플루엔자 b형 바이러스를 중화시킬 수 있는 인간 결합분자
AU2012343981B2 (en) * 2011-11-28 2017-09-07 Janssen Vaccines & Prevention B.V. Influenza virus vaccines and uses thereof
KR102252163B1 (ko) 2013-05-30 2021-05-14 얀센 백신스 앤드 프리벤션 비.브이. 인플루엔자 바이러스 백신 및 그의 용도
MX2017000395A (es) 2014-07-10 2018-02-08 Janssen Vaccines & Prevention Bv Vacunas contra virus influenza y usos de las mismas.
JP6735269B2 (ja) 2014-07-10 2020-08-05 ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． インフルエンザウイルスワクチンおよびその使用

Also Published As

Publication number Publication date
EA201592306A1 (ru) 2016-05-31
JP2016525889A (ja) 2016-09-01
MX2015016382A (es) 2016-10-14
AU2014273173A1 (en) 2015-12-10
EP3004142A1 (en) 2016-04-13
BR112015029635A2 (pt) 2017-09-26
ZA201509229B (en) 2022-03-30
KR102252163B1 (ko) 2021-05-14
NZ715583A (en) 2021-02-26
SG11201509663PA (en) 2015-12-30
AU2014273173B2 (en) 2018-09-27
EP3004142B1 (en) 2020-09-30
PH12015502612A1 (en) 2016-02-29
CN105452270A (zh) 2016-03-30
CA2913859C (en) 2021-11-30
PH12015502612B1 (en) 2016-02-29
CA2913859A1 (en) 2014-12-04
MY190097A (en) 2022-03-28
WO2014191435A1 (en) 2014-12-04
EA034639B1 (ru) 2020-03-02
US10517941B2 (en) 2019-12-31
MX369317B (es) 2019-11-05
BR112015029635B1 (pt) 2023-05-02
US20160136262A1 (en) 2016-05-19
CN105452270B (zh) 2020-12-01
KR20160013205A (ko) 2016-02-03
IL242824B (en) 2020-07-30
JP6643981B2 (ja) 2020-02-12

Similar Documents

Publication Publication Date Title
IL261204A (en) Influenza virus vaccines and their use
IL262123A (en) Influenza virus vaccines and their uses
HK1223110A1 (zh) 流行性感冒病毒疫苗及其用途
ZA201700165B (en) Influenza virus vaccines and uses thereof
HK1214962A1 (zh) 流感病毒免疫原性組合物及其應用
HK1222882A1 (zh) 流感病毒重配
HK1199211A1 (zh) 流感病毒疫苗及其用途
IL240936B (en) Reassortment of influenza virus and methods for their preparation
IL240504A0 (en) Combined vaccine for respiratory syncytial virus and influenza
SG11201610443WA (en) Influenza virus vaccines and uses thereof
HK1220656A1 (zh) 減弱的流感病毒和疫苗
IL244354B (en) Flu vaccine and treatment
HK1223644A1 (zh) 呼吸道合胞病毒半活疫苗
HK1217638A1 (zh) 流感病毒重配
HK1223643A1 (zh) 呼吸道合胞病毒半活疫苗
HK1201283A1 (zh) 丙型流感病毒和疫苗
GB201301119D0 (en) Viral vaccines
HK1219904A1 (zh) 針對多種登革病毒亞型的新穎疫苗
SG11201507455WA (en) Hepatitis b virus vaccines
IL249705A0 (en) Influenza virus vaccines and their uses
IL249704A0 (en) Influenza virus vaccines and their uses
GB201323103D0 (en) HIV vaccine and cure

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20240526